Literature DB >> 21841125

Mutations in a dominant Nef epitope of simian immunodeficiency virus diminish TCR:epitope peptide affinity but not epitope peptide:MHC class I binding.

Evan M Cale1, Heidi S Bazick, Tony A Rianprakaisang, S Munir Alam, Norman L Letvin.   

Abstract

Viruses like HIV and SIV escape from containment by CD8(+) T lymphocytes through generating mutations that interfere with epitope peptide:MHC class I binding. However, mutations in some viral epitopes are selected for that have no impact on this binding. We explored the mechanism underlying the evolution of such epitopes by studying CD8(+) T lymphocyte recognition of a dominant Nef epitope of SIVmac251 in infected Mamu-A*02(+) rhesus monkeys. Clonal analysis of the p199RY-specific CD8(+) T lymphocyte repertoire in these monkeys indicated that identical T cell clones were capable of recognizing wild-type (WT) and mutant epitope sequences. However, we found that the functional avidity of these CD8(+) T lymphocytes for the mutant peptide:Mamu-A*02 complex was diminished. Using surface plasmon resonance to measure the binding affinity of the p199RY-specific TCR repertoire for WT and mutant p199RY peptide:Mamu-A*02 monomeric complexes, we found that the mutant p199RY peptide:Mamu-A*02 complexes had a lower affinity for TCRs purified from CD8(+) T lymphocytes than did the WT p199RY peptide:Mamu-A*02 complexes. These studies demonstrated that differences in TCR affinity for peptide:MHC class I ligands can alter functional p199RY-specific CD8(+) T lymphocyte responses to mutated epitopes, decreasing the capacity of these cells to contain SIVmac251 replication.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21841125      PMCID: PMC3175636          DOI: 10.4049/jimmunol.1101080

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  84 in total

Review 1.  Antagonists or altruists: do viral mutants modulate T-cell responses?

Authors:  M P Davenport
Journal:  Immunol Today       Date:  1995-09

2.  Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR.

Authors:  B K al-Ramadi; M T Jelonek; L F Boyd; D H Margulies; A L Bothwell
Journal:  J Immunol       Date:  1995-07-15       Impact factor: 5.422

3.  A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists.

Authors:  D S Lyons; S A Lieberman; J Hampl; J J Boniface; Y Chien; L J Berg; M M Davis
Journal:  Immunity       Date:  1996-07       Impact factor: 31.745

4.  Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression.

Authors:  S Koenig; A J Conley; Y A Brewah; G M Jones; S Leath; L J Boots; V Davey; G Pantaleo; J F Demarest; C Carter
Journal:  Nat Med       Date:  1995-04       Impact factor: 53.440

Review 5.  Essential flexibility in the T-cell recognition of antigen.

Authors:  G J Kersh; P M Allen
Journal:  Nature       Date:  1996-04-11       Impact factor: 49.962

6.  Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses.

Authors:  S McAdam; P Klenerman; L Tussey; S Rowland-Jones; D Lalloo; R Phillips; A Edwards; P Giangrande; A L Brown; F Gotch
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

7.  Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes.

Authors:  T H Finkel; G Tudor-Williams; N K Banda; M F Cotton; T Curiel; C Monks; T W Baba; R M Ruprecht; A Kupfer
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

8.  T-cell-receptor affinity and thymocyte positive selection.

Authors:  S M Alam; P J Travers; J L Wung; W Nasholds; S Redpath; S C Jameson; N R Gascoigne
Journal:  Nature       Date:  1996-06-13       Impact factor: 49.962

9.  Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants.

Authors:  U C Meier; P Klenerman; P Griffin; W James; B Köppe; B Larder; A McMichael; R Phillips
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

10.  Antagonist HIV-1 Gag peptides induce structural changes in HLA B8.

Authors:  S W Reid; S McAdam; K J Smith; P Klenerman; C A O'Callaghan; K Harlos; B K Jakobsen; A J McMichael; J I Bell; D I Stuart; E Y Jones
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

View more
  4 in total

1.  Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1.

Authors:  Jonathan M Carlson; Chanson J Brumme; Eric Martin; Jennifer Listgarten; Mark A Brockman; Anh Q Le; Celia K S Chui; Laura A Cotton; David J H F Knapp; Sharon A Riddler; Richard Haubrich; George Nelson; Nico Pfeifer; Charles E Deziel; David Heckerman; Richard Apps; Mary Carrington; Simon Mallal; P Richard Harrigan; Mina John; Zabrina L Brumme
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

2.  HIV control is mediated in part by CD8+ T-cell targeting of specific epitopes.

Authors:  Florencia Pereyra; David Heckerman; Jonathan M Carlson; Carl Kadie; Damien Z Soghoian; Daniel Karel; Ariel Goldenthal; Oliver B Davis; Charles E DeZiel; Tienho Lin; Jian Peng; Alicja Piechocka; Mary Carrington; Bruce D Walker
Journal:  J Virol       Date:  2014-08-27       Impact factor: 5.103

Review 3.  Evasion of influenza A viruses from innate and adaptive immune responses.

Authors:  Carolien E van de Sandt; Joost H C M Kreijtz; Guus F Rimmelzwaan
Journal:  Viruses       Date:  2012-09-03       Impact factor: 5.048

4.  TCR affinity associated with functional differences between dominant and subdominant SIV epitope-specific CD8+ T cells in Mamu-A*01+ rhesus monkeys.

Authors:  Christa E Osuna; Ana Maria Gonzalez; Hsun-Hsien Chang; Amy Shi Hung; Elizabeth Ehlinger; Kara Anasti; S Munir Alam; Norman L Letvin
Journal:  PLoS Pathog       Date:  2014-04-17       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.